Identifying Vulnerable Atherosclerotic Plaque in Rabbits Using DMSA-USPIO Enhanced Magnetic Resonance Imaging to Investigate the Effect of Atorvastatin-Reference-Cited by-同舟云学术

Identifying Vulnerable Atherosclerotic Plaque in Rabbits Using DMSA-USPIO Enhanced Magnetic Resonance Imaging to Investigate the Effect of Atorvastatin

Published:2015-05-14 Issue:5 Volume:10 Page:e0125677
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Qi Chunmei,Deng Liangrong,Li Dongye,Wu Weiheng,Gong Lei,Li Yong,Zhang Qingdui,Zhang Tao,Zhang Chao,Zhang Yu

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference36 articles.

1. The fat-fed apolipoprotein E knockout mouse brachiocephalic artery in the study of atherosclerotic plaque rupture;AR Bond;J Biomed Biotechnol,2011

2. Characteristics of plaque disruption by intravascular ultrasound in women presenting with myocardial infarction without obstructive coronary artery disease;SN Iqbal;Am Heart J,2014

3. Coronary atherosclerosis imaging by coronary CT angiography: current status, correlation with intravascular interrogation and meta-analysis;S Voros;JACC Cardiovasc Imaging,2011

4. Intravascular detection of the vulnerable plaque;WM Suh;Circ Cardiovasc Imaging,2011

5. Detection of Vulnerable Atherosclerotic Plaque and Prediction of Thrombosis Events in a Rabbit Model Using ¹⁸F-FDG-PET/CT;Q-m Zhao;PLOS ONE,2013

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Iron and atherosclerosis: Lessons learned from rabbits relevant to human disease;Free Radical Biology and Medicine;2023-11

2. Desipramine enhances the stability of atherosclerotic plaque in rabbits monitored with molecular imaging;PLOS ONE;2023-03-30

3. Assessment of Albumin ECM Accumulation and Inflammation as Novel In Vivo Diagnostic Targets for Multi-Target MR Imaging;Biology;2021-09-27

4. Iron Oxide Nanoparticles in Regenerative Medicine and Tissue Engineering;Nanomaterials;2021-09-08

5. Pro-inflammatory Cytokines in Acute Coronary Syndromes;Current Pharmaceutical Design;2020-10-23